Virtual Biopsy
Total Trials
1
As Lead Sponsor
0
As Collaborator
Total Enrollment
30
NCT06410248
Triapine in Combination With Temozolomide for the Treatment of Patients With Recurrent Glioblastoma
Phase: Phase 1
Role: Collaborator
Start: Jul 23, 2024
Completion: May 12, 2030
Loading map...